BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20383543)

  • 1. Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.
    Pinto JT; Lee JI; Sinha R; MacEwan ME; Cooper AJ
    Amino Acids; 2011 Jun; 41(1):29-41. PubMed ID: 20383543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.
    Lee JI; Nian H; Cooper AJ; Sinha R; Dai J; Bisson WH; Dashwood RH; Pinto JT
    Cancer Prev Res (Phila); 2009 Jul; 2(7):683-93. PubMed ID: 19584079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.
    Nian H; Bisson WH; Dashwood WM; Pinto JT; Dashwood RH
    Carcinogenesis; 2009 Aug; 30(8):1416-23. PubMed ID: 19528666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.
    Pinto JT; Krasnikov BF; Alcutt S; Jones ME; Dorai T; Villar MT; Artigues A; Li J; Cooper AJ
    J Biol Chem; 2014 Nov; 289(45):30950-61. PubMed ID: 25231977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium.
    Gromer S; Gross JH
    J Biol Chem; 2002 Mar; 277(12):9701-6. PubMed ID: 11782468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver.
    Okuno T; Ueno H; Nakamuro K
    Biol Trace Elem Res; 2006 Feb; 109(2):155-71. PubMed ID: 16444005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
    Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
    Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of enzymic alpha, gamma-elimination reaction in detoxification pathway of selenomethionine in mouse liver.
    Okuno T; Kubota T; Kuroda T; Ueno H; Nakamuro K
    Toxicol Appl Pharmacol; 2001 Oct; 176(1):18-23. PubMed ID: 11578145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of cytosolic beta-elimination reactions of selenocysteine Se-conjugates in rat and human.
    Rooseboom M; Vermeulen NP; Groot EJ; Commandeur JN
    Chem Biol Interact; 2002 Aug; 140(3):243-64. PubMed ID: 12204580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids.
    Spallholz JE; Palace VP; Reid TW
    Biochem Pharmacol; 2004 Feb; 67(3):547-54. PubMed ID: 15037206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mouse selenomethionine alpha,gamma-elimination enzyme: cystathionine gamma-lyase catalyzes its reaction to generate methylselenol.
    Okuno T; Motobayashi S; Ueno H; Nakamuro K
    Biol Trace Elem Res; 2005; 108(1-3):245-57. PubMed ID: 16327076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants.
    Cooper AJ
    Neurochem Int; 2004 Jun; 44(8):557-77. PubMed ID: 15016471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol.
    Wang Z; Jiang C; Lü J
    Mol Carcinog; 2002 Jul; 34(3):113-20. PubMed ID: 12112305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparative Biocatalytic Synthesis of α-Ketomethylselenobutyrate-A Putative Agent for Cancer Therapy.
    Nikulin MV; Drobot VV; Shurubor YI; Švedas VK; Krasnikov BF
    Molecules; 2023 Aug; 28(17):. PubMed ID: 37687007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin B6 enzymes participating in selenium amino acid metabolism.
    Soda K; Oikawa T; Esaki N
    Biofactors; 1999; 10(2-3):257-62. PubMed ID: 10609891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of low-molecular-mass organoselenium compounds (and their sulphur analogues) with inflammation-associated oxidants.
    Carroll L; Davies MJ; Pattison DI
    Free Radic Res; 2015 Jun; 49(6):750-67. PubMed ID: 25854915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of free seleno-amino acids in plant tissue of Melilotus indica L. grown in selenium-laden soils.
    Guo X; Wu L
    Ecotoxicol Environ Saf; 1998 Mar; 39(3):207-14. PubMed ID: 9570912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of mouse hepatic enzyme that converts selenomethionine to methylselenol by its alpha,gamma-elimination.
    Okuno T; Motobayashi S; Ueno H; Nakamuro K
    Biol Trace Elem Res; 2005 Jul; 106(1):77-94. PubMed ID: 16037612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment.
    Gandin V; Khalkar P; Braude J; Fernandes AP
    Free Radic Biol Med; 2018 Nov; 127():80-97. PubMed ID: 29746900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.